Travere Therapeutics
TVTX
TVTX
113 hedge funds and large institutions have $1.03B invested in Travere Therapeutics in 2017 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 46 increasing their positions, 29 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
5% more funds holding
Funds holding: 108 → 113 (+5)
0.56% more ownership
Funds ownership: 106.98% → 107.54% (+0.56%)
Holders
113
Holding in Top 10
5
Calls
$13.3M
Puts
$1.7M
Top Buyers
| 1 | +$26.6M | |
| 2 | +$17.1M | |
| 3 | +$6.73M | |
| 4 |
Millennium Management
New York
|
+$6.48M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$3.84M |
Top Sellers
| 1 | -$28.5M | |
| 2 | -$12.4M | |
| 3 | -$7.53M | |
| 4 |
ORI
Oak Ridge Investments
Chicago,
Illinois
|
-$7.05M |
| 5 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$5.47M |